FDA Inspection 1330826 — American Red Cross-Myrtle Beach
The FDA completed an inspection of American Red Cross-Myrtle Beach on Jul 9, 2026 in Myrtle Beach, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 9, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Myrtle Beach, SC (United States)